Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Samelisant in Narcolepsy With or Without Cataplexy
NCT07540364Phase 3Recruiting
- Sponsor
- Suven Life Sciences
- Start
- Sep 2026
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Samelisant in narcolepsy, sponsored by Suven Life Sciences. Started Sep 2026; status: recruiting.
02
Drugs
Samelisant
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT07540364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07540364.